On-Call Symptom Interventions for Patients Receiving Bispecific T-Cell Engagers
Last Updated: July 1, 2025
On-Call Symptom Interventions for Patients Receiving Bispecific T-Cell Engagers (Mid-sized, Community Cancer Clinic)
Find Similar Resources:
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Up Close with Linvoseltamab
Last Updated: 08/31/2025
Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings
Last Updated: 08/31/2025
Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure
Last Updated: 08/31/2025
Example SOPs and Documents: Bispecific T-Cell Engager Ordering and REMS Compliance
Last Updated: 08/31/2025
PQI
PQI Podcast
Treatment Support Kit
PQI
PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC
Author: Stefanie Houseknecht, PharmD, BCOP
Last Updated: 08/31/2025
S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice
Author: Ginger Blackmon, PharmD | Deborah Wong, MD, PhD
Last Updated: 08/31/2025
Treatment Support Kit: Elranatamab
Last Updated: 08/31/2025
PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer
Author: Shelbie Gibbs, PharmD, BCOP
Last Updated: 08/31/2025